PodcastsCiênciaESC TV Today – Your Cardiovascular News

ESC TV Today – Your Cardiovascular News

European Society of Cardiology
ESC TV Today – Your Cardiovascular News
Último episódio

123 episódios

  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.13: Extended interview on the management of heart failure in cardiac amyloidosis

    09/07/2026 | 14min
    Host: Emer Joyce
    Guests: Marianna Fontana
    Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2551
     
    Disclaimer 
    ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium.
    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.13: AI & digital solutions in emergency medicine - Management of heart failure in cardiac amyloidosis

    09/07/2026 | 21min
    This episode covers:
    Cardiology This Week: A concise summary of recent studies
    AI & digital solutions in emergency medicine
    Management of heart failure in cardiac amyloidosis
    Spotlight: Orthodexia-Platypnoea Syndrome
    Host: Emer Joyce
    Guests: Marianna Fontana, Wolf Hautz, Konstantinos Koskinas
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2551
    Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview
     
    Disclaimer 
    ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Yasmina Bououdina, Wolf Hautz and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. 
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium.
    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.12: Extended interview on PCI guidance by intracoronary imaging

    25/06/2026 | 20min
    Host: Emer Joyce Guest:
    Lorenz Raeber
    Want to watch that extended interview on https://esc365.escardio.org/event/2558?resource=interview
    Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2558
     
    Disclaimer
    ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.12: Potassium in heart failure - PCI guidance by intracoronary imaging

    25/06/2026 | 21min
    This episode covers:
    Cardiology This Week: A concise summary of recent studies
    Host: Emer Joyce
    Guests: Yasmina Bououdina, JP Carpenter, Milton Packer, Lorenz Raeber
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2558
    Want to watch that extended interview on PCI guidance by intracoronary imaging, go to: https://esc365.escardio.org/event/2558?resource=interview
     
    Disclaimer 
    ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.
    Milton Packer has declared to have potential conflicts of interest to report: 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, ARMGO, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Daiichi Sankyo, Imara, Lilly, Medtronic, Moderna, Novartis, NovoNordisk, Pharmacocosmos, Regeneron, Roche, Salamandra.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.11: Extended interview on transcatheter treatment of tricuspid regurgitation

    11/06/2026 | 11min
    Host: Wilfried Mullens
    Guest: Stephan Baldus
    Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview
    Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560
     
    Disclaimer
    ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Mais podcasts de Ciência
Sobre ESC TV Today – Your Cardiovascular News
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, HFA Cardio Talk and much more. Check them out!
Sítio Web de podcast

Ouve ESC TV Today – Your Cardiovascular News, StarTalk Radio e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
ESC TV Today – Your Cardiovascular News: Podcast do grupo
Aplicações
Social
v8.11.2| © 2007-2026 radio.de GmbH
Generated: 7/11/2026 - 3:24:37 PM